Drug Development Pharma - January 31, 2014
AstraZeneca joins cancer consortium
Together with DKFZ and EORTC, AstraZeneca has joined the Worldwide Innovative Network (WIN) Consortium in personalized cancer medicine. WIN is a lobal network of academics, industries, payors and patient advocacy organizations which goal is to significantly improve survival and quality of life of cancer patients in the next three years. It was initiated in 2010 with leadership from the […]